foxo4-dri human trial

foxo4-dri human trial senolytic peptide Computational design of targeting FOXO4. a, Domains of FOXO4 foxo4 dri senolytic 2024 study – FOXO4-DRI 10mg vial - Description

Name: foxo4-dri human trial senolytic peptide Computational design of targeting FOXO4. a, Domains of FOXO4 foxo4 dri senolytic 2024 study – FOXO4-DRI 10mg vial - Description
Brand: actil.am
SKU: 46180433629
Price: 29.43 USD
Availability: InStock
Rating: 4.18 (16 reviews)

SKU: 46180433629

4.2

USD29.43 USD52.43

Pay in 4 interest-free payments of $7.36 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

The Phase II study is expected to read out in mid-2025

foxo4-dri human trial senolytic peptide Computational design of targeting FOXO4. a, Domains of FOXO4 foxo4 dri senolytic 2024 study FOXO4-DRI 10mg vial - Description

Missing data for the trial product estimand were handled through multiple imputation using the Markov Chain Monte Carlo method, assuming that non-adherent participants would have responded similarly to adherent participants within the same treatment arm

Most users dose both at the same time on the same day